S'abonner

Building a 3D “bronchioid” to model chronic obstructive pulmonary disease (COPD) - 17/02/23

Doi : 10.1016/j.rmr.2022.11.016 
E. Maurat 1, 2, , L. Andrique 3, P. Nassoy 4, G. Recher 4, I. Dupin 1, 2
1 Université Bordeaux, centre de recherche cardiothoracique de Bordeaux, U1045, département de pharmacologie, CIC 1401, Bordeaux, France 
2 Inserm, centre de recherche cardiothoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France 
3 Université Bordeaux, Plateform VoxCell, CNRS UME 3427, Inserm US005, Bordeaux, France 
4 Université Bordeaux, laboratoire photonique, numérique et nanosciences, UMR 5298 CNRS, Bordeaux, France 

Corresponding author.

Résumé

Introduction

Chronic obstructive pulmonary disease (COPD) is a major public health disease characterized by chronic inflammation and remodelling. The lack of physiological relevance of traditional 2D cell culture models, as well as the limited predictibility of tests performed in animal models, strongly limit drug discovery.

Methods

In the present project, we aim to develop a 3D “bronchioid” model recapitulating the morphological and functional characteristics of distal airway, with a permissive and remodelable environment, using an innovative tubuloid cell-based assay and bronchial adult stem cell cells derived from clinical samples. Working with the unique cellular capsule technology [1, 2], we can produce a tubular scaffold made of alginate gel that will drive the spontaneous self-organisation of lung cells.

Results

Our results show that fine tuning the balance between adhesion and contraction is required to obtain a model of bronchiole, with physiologically relevant shape and size. 3D imaging of organoids made of primary bronchial epithelial cells demonstrates the tubular organization and the existence of a lumen, as well as proper differentiation into ciliated and mucous cells. The bronchioid is perfusable, with medium or with air.

Conclusion

We provide here a proof of concept that we are able to build of a perfusable bronchioid, with proper mucociliary and contractile functions. Key advantages of our approach, such as the air–liquid interface, the lumen accessibility, and possible assessment of clinically pertinent endpoints, will make our pulmonary organoid a powerful tool for preclinical studies.

Le texte complet de cet article est disponible en PDF.

Plan


© 2022  Publié par Elsevier Masson SAS.
Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 40 - N° 2

P. 116 - février 2023 Retour au numéro
Article précédent Article précédent
  • Targeting CXCR4 as a therapeutic strategy to improve outcomes in a mouse model of early chronic obstructive pulmonary disease (COPD)
  • I. Dupin, P. Henrot, R. Abohalaka, E. Maurat, E. Eyraud, P. Esteves, M. Zysman, M. Campagnac, M. Dubreuil, G. Cardouat, C. Bouchet, O. Ousova, T. Trian, V. Freund-Michel, P. Berger
| Article suivant Article suivant
  • Caractérisation des marqueurs pulmonaires de la voie Hedgehog dans la bronchopneumopathie chronique obstructive
  • L. Petit, R. Belgacemi, J. Ancel, P. Mulette, M. Polette, G. Deslée, J.M. Perotin, V. Dormoy

Déjà abonné à cette revue ?